Rendrevie Sun Screen SPF35 PA (Cellinbio Co Ltd)
Welcome to the PulseAid listing for the Rendrevie Sun Screen SPF35 PA drug offered from Cellinbio Co Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cellinbio Co Ltd |
NON-PROPRIETARY NAME: | OCTINOXATE, TITANIUM DIOXIDE, OCTISALATE |
SUBSTANCE NAME: | OCTINOXATE; TITANIUM DIOXIDE; OCTISALATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2011-07-20 |
END MARKETING DATE: | 0000-00-00 |
Rendrevie Sun Screen SPF35 PA HUMAN OTC DRUG Details:
Item Description | Rendrevie Sun Screen SPF35 PA from Cellinbio Co Ltd |
LABELER NAME: | Cellinbio Co Ltd |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5.625; 3.89; 2.25(mL/75mL; mL/75mL; mL/75mL) |
START MARKETING DATE: | 2011-07-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76173-1001_7c58d52c-941e-4806-8348-388e1b92c62f |
PRODUCT NDC: | 76173-1001 |
APPLICATION NUMBER: | part352 |
Other OCTINOXATE; TITANIUM DIOXIDE; OCTISALATE Pharmaceutical Manufacturers / Labelers: